STAMFORD, Conn.--(BUSINESS WIRE)--Aug. 12, 2024-- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences this fall:

• UBS Genomic Medicine Summit – August 13-14, 2024
  Dana Point, California
  Future of Genetic Testing - Babies and Beyond Panel on Wednesday, August 14 at 8:00 a.m. PT
• Morgan Stanley Healthcare Conference - September 4-6, 2024
  New York, New York
• Wells Fargo Healthcare Conference - September 4-6, 2024
  Boston, Massachusetts
  Fireside chat on Thursday, September 5 at 8:45 a.m. ET
• Jefferies London Healthcare Conference - November 19-21, 2024
  London, England

Live and archived webcasts of select presentations will be available on the “Events” section of the GeneDx investor relations website at ir.genedx.com/news-events/events.

About GeneDx

At GeneDx (Nasdaq: WGS), we believe that everyone deserves personalized, targeted medical care—and that it all begins with a genetic diagnosis. Fueled by one of the world’s largest rare disease data sets, our industry-leading exome and genome tests translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It all starts with a single test. For more information, please visit genedx.com and connect with us on LinkedIn, X, Facebook, and Instagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240812959337/en/

Investor Relations Contact:
investors@GeneDx.com

Media Contact:
press@GeneDx.com

Source: GeneDx